Moreover, PD-1 or PD-L1 blockade with therapeutical antibodies still effectively eradiated the outgrowing tumors, which suggests an additional role for PD-L1 on host-derived immune cells within the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.